Downstream Processability of Crystal Habit-Modified Active Pharmaceutical Ingredient

Efficient downstream processing of active pharmaceutical ingredients (APIs) can depend strongly on their particulate properties, such as size and shape distributions. Especially in drug products with high API content, needle-like crystal habit of an API may show compromised flowability and tabletability, creating significant processability difficulties on a production scale. However, such a habit can be adapted to the needs of downstream processing. To this end, we modified the needle-like crystal habit of the model API 5-aminosalicylic acid (5-ASA). This study reports processability assessment of six representative crystal habits of 5-ASA (needles, plates, rectangular bars, rhombohedrals, elongated hexagons, and spheroids) in the context of direct compression using ring shear tester, flow rate analyzer, and instrumented tablet press. As expected, needles were very cohesive, had low flow rate (1.0 ± 0.08 mg/s), and low bulk density (0.14 ± 0.01 g/mL) but showed better tabletability, whereas the opposite w...

[1]  Hydrogen bonds in the crystal packings of mesalazine and mesalazine hydrochloride , 1997 .

[2]  Changquan Calvin Sun,et al.  Quantifying effects of particulate properties on powder flow properties using a ring shear tester. , 2008, Journal of pharmaceutical sciences.

[3]  Changquan Calvin Sun,et al.  Analytical method development for powder characterization: Visualization of the critical drug loading affecting the processability of a formulation for direct compression. , 2016, Journal of pharmaceutical and biomedical analysis.

[4]  A. Bansal,et al.  Modification of the crystal habit of celecoxib for improved processability , 2007, The Journal of pharmacy and pharmacology.

[5]  T. Lundstedt,et al.  Application of Multivariate Analysis in Pharmaceutical Development Work , 1995 .

[6]  I. Sˇirola,et al.  Effect of crystal size and shape on bulk density of pharmaceutical powders , 1997 .

[7]  Andrea R. Browning,et al.  Crystal Shape Engineering , 2008 .

[8]  A. Rohl Computer prediction of crystal morphology , 2003 .

[9]  Changquan Calvin Sun,et al.  Development of a high drug load tablet formulation based on assessment of powder manufacturability: moving towards quality by design. , 2009, Journal of pharmaceutical sciences.

[10]  J. Newton,et al.  Determination of tablet strength by the diametral-compression test. , 1970, Journal of pharmaceutical sciences.

[11]  Changquan Calvin Sun Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester , 2016 .

[12]  Sampsa Laine,et al.  Visualization of particle size and shape distributions using self-organizing maps , 2002 .

[13]  Matthew G. Heasley,et al.  Determination of the tensile strength of elongated tablets , 2013 .

[14]  Michał Teżyk,et al.  Recent progress in continuous and semi-continuous processing of solid oral dosage forms: a review , 2016, Drug development and industrial pharmacy.

[15]  Robin Taylor,et al.  New software for searching the Cambridge Structural Database and visualizing crystal structures. , 2002, Acta crystallographica. Section B, Structural science.

[16]  Michael Leane,et al.  A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms , 2015, Pharmaceutical development and technology.

[17]  Jukka Rantanen,et al.  Evaluation of ring shear testing as a characterization method for powder flow in small-scale powder processing equipment. , 2014, International journal of pharmaceutics.

[18]  J. Yliruusi,et al.  Development of a New Method to Get a Reliable Powder Flow Characteristics Using Only 1 to 2 g of Powder , 2010, AAPS PharmSciTech.

[19]  I. Bruno,et al.  Cambridge Structural Database , 2002 .

[20]  Changquan Calvin Sun,et al.  Influence of Crystal Structure on the Tableting Properties of Sulfamerazine Polymorphs , 2001, Pharmaceutical Research.

[21]  A. Bansal,et al.  Spherical Crystallization of Mebendazole to Improve Processability , 2008 .

[22]  Changquan Calvin Sun,et al.  Impact of Crystal Habit on Biopharmaceutical Performance of Celecoxib , 2013 .

[23]  L. Christrup,et al.  Patients' evaluation of shape, size and colour of solid dosage forms , 2001, Pharmacy World and Science.

[24]  M. Ward,et al.  Face-Discriminating Dissolution Kinetics of Furosemide Single Crystals: In Situ Three-Dimensional Multi-Microscopy and Modeling , 2016 .